Delivery of sTRAIL variants by MSCs in combination with cytotoxic drug treatment leads to p53-independent enhanced antitumor effects

Rui Yu, Laura Deedigan, Stella Maris Albarenque, Andrea Mohr, Ralf M. Zwacka

Cell Death and Disease · 2013 · 45 citations · 38 references

DOIFull text

Open access

References

38